Unfortunately we have to be patient.
MSB are reliant on other parties:
Rely on NIH providing the stats
Rely on the FDA booking in a meeting time, and hopefully being more forward thinking and trusting experts this time
Rely on big companies deciding to partner / fund MSB
MSB alone cannot make this happen, I imagine they would love to have this sorted out already.
No advice, although more patience by me would be helpful.
Ann: Mesoblast Operational Highlights and Upcoming Milestones, page-33
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |